{ "items": [ "\n\n
\n \n\n \n \n \n \n OPDC News\n \n \n \n \n Postdoctoral\n \n \n \n \n Publication\n \n \n \n \n Research\n \n \n \n \n Wade-Martins Group News\n \n \n\n \n\n\n
\n \n\n \n11 April 2019
\n \n \n \nA new study from OPDC Career Development Fellow Natalie Connor-Robson investigates how mutations in the gene LRRK2, which are known to cause Parkinson\u2019s, affect normal cell function.
\n \n\n \n \n\n \n\n \n \n \n \n OPDC News\n \n \n\n \n\n\n
\n \n\n \n8 April 2019
\n \n \n \nThis week we raise awareness of Parkinson's Disease and related disorders with a unique video insight into the work of the Wade-Martins Group.
\n \n\n \n \n\n \n\n \n \n \n \n OPDC News\n \n \n \n \n Research\n \n \n \n \n Wade-Martins Group News\n \n \n\n \n\n\n
\n \n\n \n8 April 2019
\n \n \n \nThis week we raise awareness of Parkinson's Disease and related disorders with a unique video insight into the work of the Wade-Martins Group.
\n \n\n \n \n\n \n\n \n \n \n \n De Val Group News\n \n \n \n \n EDI Events\n \n \n \n \n General\n \n \n \n \n OPDC News\n \n \n \n \n Wade-Martins Group News\n \n \n\n \n\n\n
\n \n\n \n8 March 2019
\n \n \n \nA multimedia celebration of the women in our Department.
\n \n\n \n \n\n \n\n \n \n \n \n OPDC News\n \n \n \n \n Publication\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n28 February 2019
\n \n \n \n\n \n \n\n \n\n \n \n \n \n OPDC News\n \n \n\n \n\n\n
\n \n\n \n25 February 2019
\n \n \n \n\n \n \n\n \n\n \n \n \n \n OPDC News\n \n \n\n \n\n\n
\n \n\n \n21 December 2018
\n \n \n \n\n \n \n\n \n\n \n \n \n \n EDI News\n \n \n \n \n OPDC News\n \n \n \n \n Wade-Martins Group News\n \n \n\n \n\n\n
\n \n\n \n21 December 2018
\n \n \n \n\n \n \n\n \n\n \n \n \n \n OPDC News\n \n \n\n \n\n\n
\n \n\n \n21 December 2018
\n \n \n \nOPDC research highlighted in Oxford University's Discover #OxfordAI videos.
\n \n\n \n \n\n \n\n \n \n \n \n OPDC News\n \n \n \n \n Publication\n \n \n \n \n Research\n \n \n \n \n Wade-Martins Group News\n \n \n\n \n\n\n
\n \n\n \n29 November 2018
\n \n \n \nThe research, funded by Parkinson's UK, reveals that an experimental drug, tasquinimod, originally developed for prostate cancer, may have the potential to treat Parkinson's disease.
\n \n\n \n \n\n \n\n \n \n \n \n OPDC News\n \n \n\n \n\n\n
\n \n\n \n29 November 2018
\n \n \n \nA drug originally developed for prostate cancer may have exciting potential for treating Parkinson\u2019s, according to our new research published in Cell Stem Cell.
\n \n\n \n \n\n \n\n \n \n \n \n OPDC News\n \n \n\n \n\n\n
\n \n\n \n28 November 2018
\n \n \n \nOPDC Medical statistician Michael Lawton has been working on a collaboration with the OPDC and Tracking Parkinson's cohorts to better define Parkinson's. His research has revealed 4 possible subtypes of the condition.
\n \n\n \n \n\n \n\n \n \n \n \n OPDC News\n \n \n\n \n\n\n
\n \n\n \n14 November 2018
\n \n \n \nResearchers at OPDC are embarking on a new five-year study looking at the links between a condition known as Rapid Eye Movement Sleep Behaviour Disorder (RBD) and Parkinson\u2019s. Funded by the NIHR Oxford Biomedical Research Centre. The study seeks to improve the remote diagnosis and monitoring of sleep problems at home and is currently looking for people with Parkinson's and RBD to take part.
\n \n\n \n \n\n \n\n \n \n \n \n OPDC News\n \n \n\n \n\n\n
\n \n\n \n9 November 2018
\n \n \n \nStudy investigates how one common variation in genetics can increase the risk of sporadic Parkinson\u2019s.
\n \n\n \n \n\n \n\n \n \n \n \n OPDC News\n \n \n\n \n\n\n
\n \n\n \n2 November 2018
\n \n \n \n\n \n \n\n \n\n \n \n \n \n OPDC News\n \n \n\n \n\n\n
\n \n\n \n31 October 2018
\n \n \n \nWatch Mark Kelly's Parkinson Voice Project lecture presented in the Clark and Brigid Lund Parkinson's Education Center. Dr Mark Kelly is a researcher at the Oxford Parkinson\u2019s Disease Centre. He qualified at Trinity College Dublin and is currently training in general medicine with a keen interest in neurology and Parkinson\u2019s disease.
\n \n\n \n \n\n \n\n \n \n \n \n OPDC News\n \n \n\n \n\n\n
\n \n\n \n18 October 2018
\n \n \n \nOPDC's Peter Magill welcomes Lord O\u2019Shaughnessy, Parliamentary Under-Secretary of State for Health to the MRC BDNU.
\n \n\n \n \n\n \n\n \n \n \n \n OPDC News\n \n \n\n \n\n\n
\n \n\n \n4 October 2018
\n \n \n \n\n \n \n\n \n\n \n \n \n \n OPDC News\n \n \n\n \n\n\n
\n \n\n \n24 September 2018
\n \n \n \n\n \n \n\n \n\n \n \n \n \n EDI Events\n \n \n \n \n OPDC News\n \n \n \n \n Outreach\n \n \n \n \n Wade-Martins Group News\n \n \n\n \n\n\n
\n \n\n \n24 September 2018
\n \n \n \n\n \n \n